Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine
- 22 April 1999
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 17 (18), 2297-2305
- https://doi.org/10.1016/s0264-410x(98)00466-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Advances in the development and evaluation of bovine herpesvirus 1 vaccinesVeterinary Microbiology, 1996
- Molecular virology of ruminant herpesvirusesVeterinary Microbiology, 1996
- Pathogenesis of ruminant herpesvirus infectionsVeterinary Microbiology, 1996
- Novel viral vaccines for livestockVeterinary Immunology and Immunopathology, 1996
- An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccinesVeterinary Microbiology, 1996
- Bovine Herpesvirus 1 (Bhv-1(: Biology, Pathogenesis, and ControlPublished by Elsevier BV ,1995
- A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccineVaccine, 1994
- Cell-Specific Kinetics and Efficiency of Herpes Simplex Virus Type 1 Entry Are Determined by Two Distinct Phases of AttachmentVirology, 1994
- Bovine herpesvirus‐1 vaccinesImmunology & Cell Biology, 1993
- An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing β-galactosidase: Evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunizationVirology, 1992